XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

Marketable Securities | 9 Months Ended
--- | ---
Sep. 30, 2025
Investments, All Other Investments [Abstract] |
Marketable Securities | Note 5: Marketable Securities The Company classifies its marketable debt securities as available-for-sale (“AFS”) and reports them at fair value in accordance with ASC Topic 326, Measurement of Credit Losses on Financial Instruments. During the three months ended September 30, 2025, the Company sold all of its investments in marketable debt securities. As a result, there were no marketable securities outstanding as of September 30, 2025, and the proceeds were used for general operating purposes. The investments in marketable securities as of December 31, 2024 had an adjusted cost basis of $2.1 million and a market value of $2.0 million. The balances consisted of the following securities (in thousands):
Schedule of marketable securities |  |  |  |  |  |  |  |  |  |  |  |
|  | Adjusted Cost |  |  | Unrealized Gain (Loss) |  |  | Fair Value |
Corporate Bonds |  | $ | 559 |  |  | $ | (22 | ) |  | $ | 537 |
U.S. Agency and Government Sponsored Securities |  |  | 1,155 |  |  |  | (48 | ) |  |  | 1,107 |
U.S. States and Municipalities |  |  | 402 |  |  |  | (17 | ) |  |  | 385 |
Total |  | $ | 2,116 |  |  | $ | (87 | ) |  | $ | 2,029 |
The AFS securities held by the Company as of December 31, 2024 had been in an unrealized loss position for a period greater than 12 months. The Company reported the net unrealized losses in accumulated other comprehensive income (loss), a component of stockholders’ equity. As of September 30, 2025 and December 31, 2024, an allowance for credit loss was not recognized as the issuers of the securities had not established a cause for default, various rating agencies had reaffirmed each security's investment grade status and the Company did not have the intent, nor is it required to sell its securities prior to recovery. Realized losses of $8,983 and $0.1 million were recognized in earnings during the three months ended September 30, 2025 and 2024, respectively. Realized losses of $36,674 and $0.5 million were recognized in earnings during the nine months ended September 30, 2025 and 2024, respectively, primarily due to selling securities prior to maturity to provide additional liquidity for general operating needs.

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/825/tableOfContent + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration